Sponsor pipeline

Institut Curie clinical trial pipeline

Get alerts when Institut Curie's trials change
Data updated daily from ClinicalTrials.gov, last refresh 2026-10-20

What changed in the last 30 days

1 trial changed in the last 30 days: 0 stopped, 0 with notable changes, 1 with a minor change only.

  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.

Active trials by phase

Phase 1/2
1
Phase 2
7
Phase 2/3
1
Phase 3
2
Not charted: 25 active trials with no phase listed on ClinicalTrials.gov (typically behavioural, device, procedure and observational studies).

Disease areas by active trials, top 10 of 14

Breast Cancer (12) · Triple-Negative Breast Cancer (5) · Lung Cancer (3) · Pancreatic Cancer (2) · Sarcoma (2) · Cervical Cancer (1) · DLBCL (1) · Head & Neck Cancer (1) · HER2-Positive Cancer (1) · Leukemia (1)

Get alerts when Institut Curie's trials change
Status changes, date slips, and new filings: detected daily, delivered to your inbox.
Start monitoring free